Research
FDA Approves Aurinia Pharmaceuticals’ LUPKYNIS for Adult Patients with Active Lupus Nephritis
LUPKYNIS (voclosporin) is the first FDA-approved oral therapy for lupus nephritis, a condition that...
Hospital Readmission and Severe Lupus Disease Activity
Life with lupus can feel like a revolving door -- between your...
New Lab Test Identifies Lupus Flare Risk 12 Weeks in Advance
New blood test, aiSLE™ DX Flare Risk Index, identifies lupus flare risk up to 12 weeks in advance. The lab test is now available for clinical use. Note: Progentec Diagnostics, Inc., the company that developed aiSLE™ DX Flare Risk Index, also powers LupusCornerLife with lupus comes...
Coronavirus and Lupus | Things to Know
Coronavirus, also known as COVID-19, is a respiratory disease related to the common cold. Although most healthy people do not need to worry about the disease, people with lupus should be careful. This disease has been in the news lately, and COVID-19 (short for Coronavirus disease 2019) may well be...
Cenerimod: A Potential New Lupus Medication
Research is underway to measure the effectiveness of Cenerimod, a new lupus medication. Early evidence suggests it can help reduce symptoms and prevent flares. Cenerimod is a new medication being developed by the company Idorsia. It is an agonist and modulator for the
NIH Funding and Lupus
The National Institute of Health, or NIH, is a part of the federal government that is responsible for funding, facilitating, and conducting research that improves the health of the nation and the world. Autoimmune diseases, including lupus, are a major health problem for the American people. Because of...
What is the World Health Organization?
The World Health Organization is an international organization dedicated to improving the health of people all over the world through education, aid work, & research. Who is the WHO? (For once, I'm not talking about the rock opera writing, legendary band!) The World...
TULIP 2 Phase III and Type 1 Interferon Lupus Treatments
Anifrolumab, a promising type 1 interferon medication, passed its second Phase III trial. The new treatment is now eligible for approval for the treatment of lupus. Type 1 interferon medications are promising candidates for treating lupus because they reduce inflammation and temper...
Mortality Rates, Treatment Effectiveness, & Lupus
Are new lupus treatment strategies keeping people healthier? A 42-year longitudinal study found improved health outcomes and decreased mortality for people living with lupus. Measuring the success of lupus treatments can be a challenge. Though a number of tools have been developed, they...
Butterfly Rash (Malar): Telltale Lupus Symptom?
The butterfly rash is a reddish purple facial rash that appears on the faces of many Lupus Warriors. 31% - 65% of people with lupus experience the skin symptom. Many associations, funds, bloggers, and lupus advocates include a butterfly in their logos. This symbol is common as a reference to the...
Spotlight On: Judith James, M.D., Ph.D.
As both a board-certified rheumatologist and internationally-acclaimed researcher, Dr. Judith James has been instrumental in improving the lives of people with lupus & other rheumatic diseases. Even as a child, Judith James was planning for a career in medicine. “When I was 4, I told my pediatrician that I...